Penn Blood Disorders Program, Hospital of the University of Pennsylvania
Penn Blood Disorders Program, Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Emicizumab in Patients With Acquired Hemophilia A | acquired hemophilia A | Active, not recruiting | Phase 2 | 2025-11-05 | NCT05345197 |